Market Overview:
The global peptide vaccine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of cancer, technological advancements in peptide vaccine development, and rising investments by key players in this market. Based on type, the global peptide vaccine market can be segmented into solution phase synthesis (SPS) and solid phase peptide synthesis (SPPS). SPS is a more traditional method for synthesizing peptides and is used for small-molecule drugs. SPPS is a newer technology that offers several advantages over SPS, including higher yields, shorter production times, and lower costs. SPPS is expected to witness higher growth during the forecast period owing to its advantages over SPS. Based on application, the global peptide vaccine market can be segmented into prostate cancer, breast cancer, gastric cancer, lung cancer pancreatic cancer,, and others. Prostate cancer accounted for the largest share of this market in 2017 owing to high incidence rates of prostate cancers across regions worldwide. Breast Cancer was second largest application area with highest CAGR due too increase awareness about breast health globally . Pancreatic Cancer are third largest application area with highest CAGR due too lack of effective treatment options available currently .
Product Definition:
A peptide vaccine is a vaccine that uses one or more peptides as an antigen to provoke an immune response in the body. Peptide vaccines are being developed as potential therapies for cancer, infectious diseases, and allergies.
Solution Phase Synthesis (SPS):
Solution phase synthesis (SPS) is a process of synthesizing peptide or protein molecules in the presence of chemical precursors or amino acids. It’s an alternative to conventional solid-phase synthesis and has several advantages such as it can be used for large scale production, cost effectiveness, high yield and purity among others.
Solid Phase Peptide Synthesis (SPPS):
Solid-phase peptide synthesis (SPPS) is a process to make large quantities of high-quality recombinant proteins. It involves the conversion of an amino acid into a mixture of amides, which are then reacted with dihydroergotamine to form a complex with cross-linked peptide chains.
Application Insights:
The prostate cancer segment dominated the global peptide vaccine market in terms of revenue share in 2017. This can be attributed to the rising prevalence of the disease and increasing focus on male reproductive health. The breast cancer segment is expected to witness lucrative growth during the forecast period owing to increasing awareness about preventive measures against this disease, growing R&D initiatives by various companies and an increase in government funding for research related to peptide vaccines.
Gastric cancer is another application that is anticipated to witness significant growth over the forecast period due largelyto its high incidence rate globally coupled with ongoing R&D initiatives by various companies involved in peptide synthesis for potential use as a therapeutic tool against this tumorigenic cell type.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of peptide vaccine developers and manufacturers, increased funding for peptide vaccines, high prevalence of cancer in this region, and growing awareness about peptide vaccination. Moreover, increasing incidence rates of cancer has led to an increase in demand for immunotherapies that are more effective than conventional chemotherapies.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising government initiatives pertaining to development & approval of novel immunotherapeutic products coupled with increasing R&D expenditure by domestic companies.
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is expected to drive the demand for peptide vaccines over the forecast period.
- Growing awareness about the benefits of peptide vaccines is anticipated to propel their uptake in developed and developing countries.
- Technological advancements in vaccine development are likely to provide a boost to the market growth over the next few years.
- Rising investments by key players for research and development activities are projected to create new opportunities for market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Peptide Vaccine Market Research Report
By Type
Solution Phase Synthesis (SPS), Solid Phase Peptide Synthesis (SPPS)
By Application
Prostate Cancer, Breast Cancer, Gastric Cancer, Lung Cancer, Pancreatic Cancer, Others
By Companies
Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck, ImmunoCellular Therapeutics, ISA Pharmaceuticals, Anergis, Spotlight Innovation, OncoTherapy Science, Peptech, Pharmasyntez, Sumitomo Dainippon Pharma, TapImmune, Targovax
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Peptide Vaccine Market Report Segments:
The global Peptide Vaccine market is segmented on the basis of:
Types
Solution Phase Synthesis (SPS), Solid Phase Peptide Synthesis (SPPS)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Prostate Cancer, Breast Cancer, Gastric Cancer, Lung Cancer, Pancreatic Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Anergis
- Antigen Express
- Apitope Technology
- Artificial Cell Technologies
- Benovus Bio
- Celgene Corporation
- Immatics biotechnologies
- Merck
- ImmunoCellular Therapeutics
- ISA Pharmaceuticals
- Anergis
- Spotlight Innovation
- OncoTherapy Science
- Peptech
- Pharmasyntez
- Sumitomo Dainippon Pharma
- TapImmune
- Targovax
Highlights of The Peptide Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solution Phase Synthesis (SPS)
- Solid Phase Peptide Synthesis (SPPS)
- By Application:
- Prostate Cancer
- Breast Cancer
- Gastric Cancer
- Lung Cancer
- Pancreatic Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peptide Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A peptide vaccine is a vaccine composed of short peptides. Peptides are smaller proteins that can easily cross the blood-brain barrier and stimulate an immune response in the brain.
Some of the major companies in the peptide vaccine market are Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck, ImmunoCellular Therapeutics, ISA Pharmaceuticals, Anergis, Spotlight Innovation, OncoTherapy Science, Peptech, Pharmasyntez, Sumitomo Dainippon Pharma, TapImmune, Targovax.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peptide Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Peptide Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Peptide Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Peptide Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Peptide Vaccine Market Size & Forecast, 2018-2028
4.5.1 Peptide Vaccine Market Size and Y-o-Y Growth
4.5.2 Peptide Vaccine Market Absolute $ Opportunity
Chapter 5 Global Peptide Vaccine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Peptide Vaccine Market Size Forecast by Type
5.2.1 Solution Phase Synthesis (SPS)
5.2.2 Solid Phase Peptide Synthesis (SPPS)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Peptide Vaccine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Peptide Vaccine Market Size Forecast by Applications
6.2.1 Prostate Cancer
6.2.2 Breast Cancer
6.2.3 Gastric Cancer
6.2.4 Lung Cancer
6.2.5 Pancreatic Cancer
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Peptide Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Peptide Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Peptide Vaccine Analysis and Forecast
9.1 Introduction
9.2 North America Peptide Vaccine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Peptide Vaccine Market Size Forecast by Type
9.6.1 Solution Phase Synthesis (SPS)
9.6.2 Solid Phase Peptide Synthesis (SPPS)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Peptide Vaccine Market Size Forecast by Applications
9.10.1 Prostate Cancer
9.10.2 Breast Cancer
9.10.3 Gastric Cancer
9.10.4 Lung Cancer
9.10.5 Pancreatic Cancer
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Peptide Vaccine Analysis and Forecast
10.1 Introduction
10.2 Europe Peptide Vaccine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Peptide Vaccine Market Size Forecast by Type
10.6.1 Solution Phase Synthesis (SPS)
10.6.2 Solid Phase Peptide Synthesis (SPPS)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Peptide Vaccine Market Size Forecast by Applications
10.10.1 Prostate Cancer
10.10.2 Breast Cancer
10.10.3 Gastric Cancer
10.10.4 Lung Cancer
10.10.5 Pancreatic Cancer
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Peptide Vaccine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Peptide Vaccine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Peptide Vaccine Market Size Forecast by Type
11.6.1 Solution Phase Synthesis (SPS)
11.6.2 Solid Phase Peptide Synthesis (SPPS)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Peptide Vaccine Market Size Forecast by Applications
11.10.1 Prostate Cancer
11.10.2 Breast Cancer
11.10.3 Gastric Cancer
11.10.4 Lung Cancer
11.10.5 Pancreatic Cancer
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Peptide Vaccine Analysis and Forecast
12.1 Introduction
12.2 Latin America Peptide Vaccine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Peptide Vaccine Market Size Forecast by Type
12.6.1 Solution Phase Synthesis (SPS)
12.6.2 Solid Phase Peptide Synthesis (SPPS)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Peptide Vaccine Market Size Forecast by Applications
12.10.1 Prostate Cancer
12.10.2 Breast Cancer
12.10.3 Gastric Cancer
12.10.4 Lung Cancer
12.10.5 Pancreatic Cancer
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Peptide Vaccine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Peptide Vaccine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Peptide Vaccine Market Size Forecast by Type
13.6.1 Solution Phase Synthesis (SPS)
13.6.2 Solid Phase Peptide Synthesis (SPPS)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Peptide Vaccine Market Size Forecast by Applications
13.10.1 Prostate Cancer
13.10.2 Breast Cancer
13.10.3 Gastric Cancer
13.10.4 Lung Cancer
13.10.5 Pancreatic Cancer
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Peptide Vaccine Market: Competitive Dashboard
14.2 Global Peptide Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Anergis
14.3.2 Antigen Express
14.3.3 Apitope Technology
14.3.4 Artificial Cell Technologies
14.3.5 Benovus Bio
14.3.6 Celgene Corporation
14.3.7 Immatics biotechnologies
14.3.8 Merck
14.3.9 ImmunoCellular Therapeutics
14.3.10 ISA Pharmaceuticals
14.3.11 Anergis
14.3.12 Spotlight Innovation
14.3.13 OncoTherapy Science
14.3.14 Peptech
14.3.15 Pharmasyntez
14.3.16 Sumitomo Dainippon Pharma
14.3.17 TapImmune
14.3.18 Targovax
